DAVA Oncology Competitors and Similar CompaniesClear all
DAVA Oncology's competitors and similar companies include BioAtla, Elevar Therapeutics, Corvus Pharmaceuticals and GlycoMimetics.
 DAVA Oncology DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development. |  BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer. |  Elevar Therapeutics Elevar Therapeutics (previously known as LSK BioPharma) is a pharmaceutical company. |  Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | |
Founding Date | Founding Date 2007 | Founding Date 2007 | Founding Date 2005 | Founding Date 2014 | Founding Date 2003 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Dallas, US HQ | Locations San Diego, US HQ | Locations South San Francisco, US HQ Dublin, IE Salt Lake City, US | Locations Burlingame, US HQ | Locations Rockville, US HQ |
Employees | Employees 823% increase | Employees 616% decrease | Employees 565% decrease | Employees 4911% decrease | Employees 5025% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 100.8 m | Valuation ($) N/A | Valuation ($) 556.1 m | Valuation ($) 31.6 m |
Financial | |||||
Net income | Net income N/A | Net income ($59.6m) (FY, 2025) | Net income N/A | Net income ($15.3m) (FY, 2025) | Net income ($153.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 186.5m | Total funding raised $ 20m | Total funding raised N/A | Total funding raised $ 101.8m |
For sources of this data, please see the company profile
View Company Profiles
BioAtla
HQ
San Diego, US
Employees
61↓ 6% decrease
BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
View companyElevar Therapeutics
HQ
South San Francisco, US
Employees
56↓ 5% decrease
Elevar Therapeutics (previously known as LSK BioPharma) is a pharmaceutical company.
View companyCorvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
View companyGlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company